Skip to main content
    I

    iBio, Inc. Common Stock (IBIO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.71
    -0.02 (-3.42%)

    Market Cap: $51.55M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    iBio, Inc. Common Stock (IBIO) Earnings: Report Dates and Results

    Updated Nov 10, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    iBio, Inc. Common Stock (IBIO) is expected to report earnings on Feb 8, 2027. In the quarter ended Sep 30, 2026, iBio, Inc. Common Stock reported EPS of -$0.05, above the -$0.07 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    41%(9/22)
    Avg Surprise
    -9.83%
    Streak
    2 Q

    Upcoming Estimates

    Reports Feb 8, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.06
    Range-$0.07 - -$0.05
    3 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago-$0.08+20.9%
    60d ago-$0.08+20.9%
    30d ago-$0.07+9.6%
    7d ago-$0.060.0%
    Current-$0.06
    Revenue Consensus
    $16.67K
    RangeN/A
    6 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.07
    Range-$0.10 - -$0.06
    7 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.08+6.9%
    60d ago-$0.09+20.7%
    30d ago-$0.09+19.1%
    7d ago-$0.09+18.0%
    Current-$0.07
    Revenue Consensus
    N/A
    RangeN/A
    6 analysts

    Next Report

    IBIO has an expected report date of Feb 8, 2027.

    Earnings History

    Of the 22 quarters below that had an estimate, IBIO beat 9, missed 11 and matched 2. The widest gap in the table came in the quarter ended Sep 30, 2022, when EPS landed 221.71% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.05-$0.07-$0.10 - -$0.05+28.57%BeatN/A70 up, 0 downNov 10, 2026N/A
    Jun 30, 2026-$0.04-$0.07-$0.09 - -$0.03+42.86%BeatN/A71 up, 0 downAug 28, 2026N/A
    Mar 31, 2026-$0.06-$0.06-$0.07 - -$0.04-2.05%MissN/A60 up, 1 downMay 12, 2026N/A
    Dec 31, 2025-$0.09-$0.06-$0.07 - -$0.06-50.00%MissN/A20 up, 0 downFeb 10, 2026N/A
    Sep 30, 2025-$0.29-$0.43N/A+32.56%BeatN/A30 up, 0 downNov 12, 2025$100000
    Jun 30, 2025-$0.32-$0.36-$0.39 - -$0.34+11.11%BeatN/A20 up, 0 downSep 5, 2025$200000
    Mar 31, 2025-$0.49-$0.32-$0.39 - -$0.25-53.13%MissN/A20 up, 0 downMay 2, 2025N/A
    Dec 31, 2024-$0.48-$0.46-$0.51 - -$0.43-4.35%MissN/A20 up, 0 downFeb 10, 2025$200000
    Sep 30, 2024-$0.46-$0.46-$0.53 - -$0.430.00%In lineN/A20 up, 0 downNov 12, 2024N/A
    Jun 30, 2024-$0.90-$0.47-$0.48 - -$0.46-91.89%MissN/A20 up, 0 downSep 25, 2024$175000
    Mar 31, 2024-$0.85N/AN/AN/AN/AN/AN/AN/AMay 13, 2024N/A
    Dec 31, 2023-$4.42N/AN/AN/AN/AN/AN/A0 up, 0 downFeb 9, 2024N/A
    Sep 30, 2023-$0.24N/AN/AN/AN/AN/AN/A0 up, 0 downNov 14, 2023$50000
    Jun 30, 2023-$1.80-$8.20N/A+78.05%BeatN/AN/AN/ASep 27, 2023N/A
    Mar 31, 2023-$11.00-$7.20N/A-52.78%MissN/A10 up, 0 downMay 11, 2023N/A
    Dec 31, 2022-$21.60-$12.50N/A-72.80%MissN/A10 up, 0 downFeb 14, 2023N/A
    Sep 30, 2022-$112.60-$35.00N/A-221.71%MissN/A20 up, 0 downOct 11, 2022N/A
    Jun 30, 2022-$1.96-$2.12-$2.25 - -$2.00+7.55%Beat-19700.0%20 up, 0 downSep 27, 2022$61000
    Mar 31, 2022-$30.00-$27.50-$30.00 - -$25.00-9.09%MissN/A20 up, 0 downMay 12, 2022$1.80M
    Dec 31, 2021-$25.00-$20.00-$20.00 - -$20.00-25.00%MissN/A20 up, 0 downFeb 14, 2022N/A
    Sep 30, 2021-$1.00-$1.25-$1.25 - -$1.25+20.00%BeatN/A1N/ANov 15, 2021$84000
    Jun 30, 2021$0.01-$20.00N/A+100.05%BeatN/AN/AN/ASep 27, 2021$491000
    Mar 31, 2021-$20.00-$20.00N/A0.00%In lineN/AN/AN/AMay 17, 2021$765000
    Dec 31, 2020-$20.00-$17.50N/A-14.29%MissN/A1N/AFeb 16, 2021$705000
    Sep 30, 2020-$10.00-$25.00N/A+60.00%BeatN/A1N/AOct 13, 2020$410000
    Mar 31, 2020-$0.06N/AN/AN/AN/AN/AN/AN/AMay 15, 2020$96000
    Dec 31, 2019-$0.69N/AN/AN/AN/AN/AN/AN/AFeb 14, 2020$314000
    Sep 30, 2019-$0.21N/AN/AN/AN/AN/AN/AN/ANov 14, 2019$108000
    Jun 30, 2019-$0.23N/AN/AN/AN/AN/AN/AN/AAug 26, 2019$795000
    Mar 31, 2019-$0.22N/AN/AN/AN/AN/AN/AN/AMay 10, 2019$527000
    Dec 31, 2018-$0.24N/AN/AN/AN/AN/AN/AN/AFeb 13, 2019$651000
    Sep 30, 2018-$0.25N/AN/AN/AN/AN/AN/AN/ANov 13, 2018$45000
    Jun 30, 2018-$0.38N/AN/AN/AN/AN/AN/AN/ASep 18, 2018$91000
    Mar 31, 2018-$0.35N/AN/AN/AN/AN/AN/AN/AMay 11, 2018$78000
    Dec 31, 2017-$0.41N/AN/AN/AN/AN/AN/AN/AFeb 14, 2018$153000
    Sep 30, 2017-$0.42N/AN/AN/AN/AN/AN/AN/ANov 9, 2017$122000
    Jun 30, 2017-$0.49N/AN/AN/AN/AN/AN/AN/ASep 15, 2017$147000
    Mar 31, 2017-$0.44N/AN/AN/AN/AN/AN/AN/AMay 15, 2017$37000
    Dec 31, 2016-$0.36N/AN/AN/AN/AN/AN/AN/AFeb 21, 2017$75000
    Sep 30, 2016-$0.34N/AN/AN/AN/AN/AN/AN/AOct 13, 2016$135000
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Jun 30, 2026 was -$0.48, after -$1.75 the year before. It was -$599.22 for the year ended Jun 30, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Jun 30, 2026-$0.48N/A
    Jun 30, 2025-$1.75N/A
    Jun 30, 2024-$6.42N/A
    Jun 30, 2023-$147.00N/A
    Jun 30, 2022-$57.96N/A
    Jun 30, 2021-$50.95N/A
    Jun 30, 2019-$0.94N/A
    Jun 30, 2018-$1.56N/A
    Jun 30, 2017-$1.64N/A
    Jun 30, 2016-$599.22N/A

    Frequently Asked Questions About IBIO

    When is iBio, Inc. Common Stock's next earnings date?

    iBio, Inc. Common Stock's next earnings report is expected for Feb 8, 2027.

    Did IBIO beat earnings estimates last quarter?

    Yes. iBio, Inc. Common Stock reported EPS of -$0.05 for the quarter ended Sep 30, 2026, above the -$0.07 estimate, a 28.57% surprise.

    What EPS do analysts expect from IBIO next quarter?

    The consensus EPS estimate for iBio, Inc. Common Stock for the quarter ending Dec 31, 2026 is -$0.06 from 3 analysts, with estimates from -$0.07 to -$0.05.

    How often does IBIO beat earnings estimates?

    iBio, Inc. Common Stock beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of +0.70%.